上海医药：关于注射用头孢呋辛钠及注射用氨曲南通过仿制药一致性评价的公告

Core Viewpoint - Shanghai Pharmaceuticals announced the approval of its injectable drugs, Cefuroxime Sodium and Aztreonam, by the National Medical Products Administration, indicating successful consistency evaluation of generic drug quality and efficacy [1] Group 1 - Shanghai Pharmaceuticals' subsidiary, Shanghai Shiyuan New Asia Pharmaceutical Co., Ltd., received approval for injectable Cefuroxime Sodium and Aztreonam [1] - The approval was granted through the issuance of Supplementary Application Approval Notices with specific notification numbers [1] - The approved drugs have passed the consistency evaluation for generic drug quality and efficacy [1]